Division of Pediatric Nephrology, UH Rainbow Babies and Children's Hospital Division of Pediatrics, Cleveland, OH, USA.
Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pediatr Transplant. 2020 Aug;24(5):e13709. doi: 10.1111/petr.13709. Epub 2020 May 10.
Medication non-adherence is an important factor limiting allograft survival after kidney transplantation in AYA. Some interventions, including the TAKE-IT, showed some success in promoting adherence but the potential for scalability and use in routine clinical practice is limited. We applied user-centered design to gather the perspectives of recipients, parents, and health professionals concerning their needs, challenges, and potential intervention strategies to design an optimal, multi-component medication adherence intervention. The qualitative study was conducted at four Canadian and three American kidney transplant programs. Separate focus groups for recipients, parents, and health professionals were convened to explore these stakeholders' perspectives. Directed content analysis was employed to identify themes that were shared vs distinct across stakeholders. All stakeholder groups reported challenges related to taking medications on time in the midst of their busy schedules and the demands of transitioning toward independence during adolescence. The stakeholders also made suggestions for the multi-component behavioral intervention, including an expanded electronic pillbox and companion website, education materials, and customized digitized features to support shared responsibility and communication among recipients, parents, and health professionals. Several suggestions regarding the functionality and features of the potential intervention reported in this early stage will be explored in more depth as the iterative process unfolds. Our approach to actively involve all stakeholders in the process increases the likelihood of designing an adherence intervention that is truly user-informed and fit for the clinical setting.
药物不依从是限制青少年及年轻成人肾移植后移植物存活的一个重要因素。一些干预措施,包括 TAKE-IT,已经显示出在促进依从性方面的一些成功,但在可扩展性和在常规临床实践中的使用方面潜力有限。我们应用以用户为中心的设计方法,收集受者、父母和卫生专业人员的意见,了解他们的需求、挑战以及潜在的干预策略,以设计出最佳的、多组分的药物依从性干预措施。这项定性研究在四个加拿大和三个美国肾脏移植项目中进行。为了探索这些利益相关者的观点,分别为受者、父母和卫生专业人员召开了焦点小组会议。采用有针对性的内容分析来确定跨利益相关者共享和独特的主题。所有利益相关者群体都报告了与在忙碌的日程中按时服药以及在青少年时期向独立过渡的需求相关的挑战。利益相关者还对多组分行为干预措施提出了建议,包括扩大电子药盒和配套网站、教育材料以及定制的数字化功能,以支持受者、父母和卫生专业人员之间的共同责任和沟通。在迭代过程中,将更深入地探讨本研究早期报告的潜在干预措施的功能和特性的一些建议。我们积极让所有利益相关者参与该过程的方法,增加了设计真正基于用户意见和适合临床环境的依从性干预措施的可能性。